InstalabT and B Cells
Should you take a T and B Cells test?
This test is most useful if any of these apply to you.
5 biomarkers included
- Lymphocyte CountThe total pool of infection-fighting lymphocytes. It sets the context for the T- and B-cell numbers and flags broad immune suppression when it drops.Why it mattersA low total is a general marker of reduced immune reserve; the subset counts reveal which arm is driving it.
- B Cells (CD19+)Counts the B cells responsible for producing antibodies. This is the compartment targeted by B-cell-depleting drugs and the one that fails in antibody deficiencies.Why it mattersA low B-cell count points to reduced antibody-making capacity, whether from an inherited deficit or B-cell-depleting therapy.
- B Cells % of Lymphocytes (CD19+)Shows what share of your lymphocytes are B cells. A rise or fall can reflect a true B-cell change or simply a shift on the T-cell side.Why it mattersAn abnormal B-cell percentage flags redistribution within the lymphocyte pool that a total count alone would not reveal.
- T Cells (CD3+)Counts the T cells that drive cellular immunity, the arm that controls viral infections and helps hold some cancers in check. Often the first compartment to fall in serious illness.Why it mattersA low T-cell count signals weakened cellular defense and, in several conditions, tracks with higher infection and mortality risk.
- T Cells % of Lymphocytes (CD3+)Shows what share of your lymphocytes are T cells, describing how the pool is composed rather than how many cells you have.Why it mattersA shifted T-cell percentage suggests one compartment has expanded or contracted relative to the other, prompting a look at the absolute counts.
About T and B Cells
Your immune system's frontline defenders come in two main types. T cells hunt down infected cells directly, and B cells make the antibodies that neutralize invaders and remember them for next time. This panel counts both.
A standard blood count tells you how many lymphocytes you have in total, but not how they are divided among their types. This panel separates out the two main adaptive-immune arms, T cells and B cells, so you can see whether your cellular defense or your antibody defense is running low before an infection exposes the gap. A third lymphocyte type, natural killer cells, is measured separately.
What This Panel Reveals
The panel measures immune defense from three angles at once: how many lymphocytes you have in total, how many of them are T cells (marked by a surface protein called CD3), and how many are B cells (marked by a protein called CD19). Each is reported two ways, as an absolute number of cells and as a percentage of your lymphocytes.
The T-cell measures track your cellular immunity, the arm that controls viruses and other threats hiding inside cells. When T-cell numbers fall, the body's ability to contain infection and to respond to some cancers tends to fall with them.
The B-cell measures track humoral immunity, your antibody-producing capacity. A low B-cell count can signal weak vaccine responses or an antibody deficiency, and B cells are the specific target of some modern drugs used for autoimmune disease and lymphoma.
Counts and percentages answer different questions. The count tells you how many defender cells you actually have available. The percentage tells you how the surviving pool is divided. Reading them together is what keeps a normal-looking ratio from hiding a real shortage.
How to Read Your Results Together
The value of this panel is in the pattern, not any single number. A total count that looks acceptable can still sit on top of a specific deficit, and the split between T and B cells is what reveals it.
| Pattern | What It Suggests |
|---|---|
| Low total count with low T cells and low B cells | Broad immune suppression, often from serious illness, chemotherapy, or medication. |
| Low T cells with preserved B cells | A mainly cellular defect, affecting the arm that fights viruses. |
| Very low B cells with preserved T cells | A mainly antibody-side deficit, the expected pattern after B-cell-depleting therapy such as rituximab. |
| Normal percentages but low absolute counts | A hidden shortage that a ratio alone would miss. |
In one study of lung cancer patients, the absolute numbers of T and B cells dropped even though their percentages stayed normal, a shortfall that percentages alone would have missed. After treatment with the B-cell drug rituximab, B-cell numbers fall to near zero while T-cell numbers hold steady, which is why an isolated empty B-cell compartment usually points to the drug rather than an inherited defect.
What to Do with Your Results
How far you follow up depends on which compartment is affected and by how much. A borderline result in someone who feels well often just needs a repeat draw. A clearly low count, especially alongside frequent or unusual infections, is worth taking to an immunologist.
These numbers carry weight. In people on dialysis, a B-cell count below 100 cells per microliter was linked to markedly lower survival, 16.5 percent versus 54 percent. In hospitalized patients with COVID-19, a T-cell count below 524 cells per microliter independently predicted death. Low counts are a reason to investigate, not to panic.
This panel is a screen, not a full map. If T cells are low, a fuller immune panel that separates helper T cells (CD4) from killer T cells (CD8) and adds natural killer cells sharpens the picture. If B cells are low, measuring antibody levels (immunoglobulins) tests whether the shortage is affecting real antibody output. Together these tell you whether a low count is doing measurable harm.
Serial tracking matters more than any single reading. Because a person's own values are steadier than the spread across the population, comparing new results to your own baseline in the same lab is the most reliable way to spot a genuine change. If you are on immune-affecting treatment, retesting every few months tracks whether your defenses are recovering or slipping.
When Results Can Be Misleading
Several things move every number in this panel at once. A recent or active infection, physical stress, steroid medication, and pregnancy can all shift lymphocyte counts temporarily, so a single abnormal result during illness is often not your true baseline. Age matters too: T-cell and B-cell counts are highest in early childhood and decline over life, which is why results must be read against age-matched ranges.
The test also only sees blood. Most of your lymphocytes live in lymph nodes, spleen, and tissue, so a blood snapshot can miss activity happening elsewhere. And because different labs use different equipment and methods, tracking a trend works best when you stay with one lab.